alexbrown

In this article TRIP A close-up of a man using an Apple iPad Mini tablet computer to research holiday destinations, January 17, 2019. Will Ireland | Future Publishing | Future | Getty Images Tripadvisor announced Wednesday the launch of Tripadvisor Plus, a travel subscription service that will provide U.S. customers with access to travel savings
0 Comments
In this article TRIP A close-up of a man using an Apple iPad Mini tablet computer to research holiday destinations, January 17, 2019. Will Ireland | Future Publishing | Future | Getty Images Tripadvisor announced Wednesday the launch of Tripadvisor Plus, a travel subscription service that will provide U.S. customers with access to travel savings
0 Comments
The best treatment strategy for COVID-linked multisystem inflammatory syndrome in children (MIS-C) remains unclear after dueling observational studies came to disparate conclusions. Starting treatment off with both IV immunoglobulin (IVIG) and glucocorticoids was associated with a lower risk of cardiovascular dysfunction on or after day 2 compared with initial IVIG alone (17% vs 31%; risk
0 Comments
Comatose out-of-hospital cardiac arrest (OHCA) survivors fared no better on targeted temperature management (TTM) than standard care for avoiding fever in the ICU, according to the TTM2 trial. There was no significant difference between the 50% incidence of all-cause death at 6 months among patients randomized to targeted hypothermia at 33°C (91.4°F) and the 48%
0 Comments
Comatose out-of-hospital cardiac arrest (OHCA) survivors fared no better on targeted temperature management (TTM) than standard care for avoiding fever in the ICU, according to the TTM2 trial. There was no significant difference between the 50% incidence of all-cause death at 6 months among patients randomized to targeted hypothermia at 33°C (91.4°F) and the 48%
0 Comments
Patients hospitalized with COVID-19 pneumonia who were treated with tofacitinib (Xeljanz) had a significantly lower incidence of death or respiratory failure than those treated with placebo, a randomized trial in Brazil found. Cumulative incidence of death or respiratory failure through day 28 was significantly lower in the tofacitinib group than in controls (18.1% vs 29.0%,
0 Comments
Patients hospitalized with COVID-19 pneumonia who were treated with tofacitinib (Xeljanz) had a significantly lower incidence of death or respiratory failure than those treated with placebo, a randomized trial in Brazil found. Cumulative incidence of death or respiratory failure through day 28 was significantly lower in the tofacitinib group than in controls (18.1% vs 29.0%,
0 Comments
The use of artificial intelligence in creating radiation treatment plans for prostate cancer appeared to be a success, according to a blinded, head-to-head study. Overall, radiation oncologists considered the vast majority — 89 of 100 — of machine learning (ML)-generated plans clinically acceptable for treatment, reported Thomas Purdie, PhD, and colleagues at Princess Margaret Cancer
0 Comments